Clinical Trials Logo

Clinical Trial Summary

The primary aim of this clinical trial is to determine the acute effects of OLIPOP (a lower sugar, high fiber prebiotic soda) consumption, compared to consumption of a commercially available sugar-sweetened soda pop, on blood glucose in response to the beverages alone and in combination with a carbohydrate-rich mixed lunch meal in free-living, generally healthy adults.This study will consist of one screening/randomization clinic visit (day 0) and one follow-up clinic visit (day 5), with participants consuming study products on their own (e.g., at home) following an assigned treatment sequence on days 1, 2, 3, and 4. The main questions answered by this trial are the impacts of a prebiotic rich soda versus a traditional soda on: 1) blood glucose levels with and without a meal, 2) perceived hunger levels, 3) perceived alertness levels and 4) total caloric intake.


Clinical Trial Description

n/a


Study Design


NCT number NCT06427915
Study type Interventional
Source Olipop, PBC
Contact Michael J Weiser, PhD
Phone ?303-834-7240
Email mweiser@drinkolipop.com
Status Recruiting
Phase N/A
Start date May 15, 2024
Completion date August 2, 2024